For Researchers

The Foundation Fighting Blindness has contributed millions of dollars to support vision research at hospitals and universities across Canada.

If you are interested in applying for one of our grant programs, please fill out the applicable forms below. All submissions are reviewed by our expert Scientific Advisory Board.

FFB Grants

2018 Funding Opportunities


Clinician-scientist ophthalmologists play an essential role in developing new sight-saving treatments. The FFB’s Clinician-Scientist Emerging Leader (CSEL) Award aims to strengthen the community of clinician-scientists with ophthalmological expertise in Canada by enabling the next generation of ophthalmologists to incorporate research into their careers. In 2018, the FFB is proud to announce a new partnership with Bayer that will allow us to support more emerging leaders, who will fuel our fight against blindness!

Click here to download the full application with details on the submission process.

July 13, 2018: Deadline to submit Full Proposal


The Foundation Fighting Blindness (FFB) is thrilled to announce the Restore Vision 20/20 Initiative, which is a new $2.5 million funding commitment to drive the development of therapies for people living with late-stage retinal degenerative diseases.

Please review the Restore Vision 20/20 Initiative General Guidelines and Letter of Intent form for further details.

May 21, 2018: Deadline to submit Letter of Intent
July 13, 2018: Deadline to submit Full Proposal

Restore Vision 20/20 Initiative General Guidelines PDF

Letter of Intent form PDF

Full Application Instructions PDF

Full Application Form PDF

Budget Template (Download Excel file)

Evaluation Process & Review Criteria PDF


Submit Application

All fields marked with an asterisk (*) are required

FFB Policies & Positions

Patent Rights Policy

Created and Implemented September 17, 2014

The Foundation Fighting Blindness (FFB) has implemented a patent rights policy for FFB-funded research. The policy can be downloaded here:


Stem Cell Research

Created March 22, 2010

Stem cell research holds promise for finding treatments for various retinal dystrophies. The Foundation Fighting Blindness (FFB) is committed to finding treatments for retinal dystrophies and supports stem cell research as per the Assisted Human Reproduction Act (AHRA), which became law in Canada in March 2004. The Act and its framework ensure the consistent and regulated conduct of research, which balances respect for human life and potential for modern science. The FFB acknowledges the highly sensitive and ethical issues addressed by the Act concerning embryonic stem cell research, and supports efforts to identify alternative sources for therapeutic applications. The FFB respects all points of view on this important topic.

For details about Assisted Human Reproduction in Canada visit

If you wish not to support embryonic stem cell research, your donation to the FFB can be directed to alternative sources for therapeutic applications, such as gene therapy or to education and public awareness.

Indirect Costs

Created May 2007

The Foundation Fighting Blindness does not provide funds for indirect costs associated with research. While the Foundation recognizes that these are indeed legitimate expenditures, we believe the funding of such costs is the responsibility of governments and/or research institutions – not donors.

The Foundation is a member in good standing of the Health Charities Coalition of Canada (HCCC). All HCCC members abide by this funding policy. See the HCCC position statement on indirect costs.